Royal Bank Of Canada Homology Medicines, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.53 - $1.14 $175 - $378	332 New	332 $0
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.12 $1,512 - $2,040	1,822 Added 121.47%	3,322 $2,000
Q1 2023 May 15, 2023	SELL	$0.91 - $1.69 $39 - $72	-43 Reduced 2.79%	1,500 $1,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $444 - $832	408 Added 35.95%	1,543 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $5,251 - $11,787	-3,778 Reduced 76.9%	1,135 $2,000

Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $13,852 - $22,217	-5,328 Reduced 52.03%	4,913 $15,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $22,906 - $48,959	6,293 Added 159.4%	10,241 $37,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $3,858 - $5,591	642 Added 19.42%	3,948 $32,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $19,902 - $31,869	3,306 New	3,306 $24,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.